Danish Commercial Services Stock News

Key Insights Per Aarsleff Holding's significant retail investors ownership suggests that the key decisions are...

Novo Nordisk (CPSE:NOVO B) shares have edged slightly higher, continuing a pattern of modest moves over the past week. Investors appear to be digesting recent financial data while assessing the stock's performance in a changing market environment. See our latest analysis for Novo Nordisk. While Novo Nordisk’s share price has bounced in the last trading session, the stock is still working to rebuild momentum after a challenging stretch. Over the past year, shareholders have seen a total return...

Amid renewed concerns over inflated AI stock valuations and receding expectations for a U.S. interest rate cut, European markets have experienced a downturn, with major indexes such as the STOXX Europe 600 and Germany's DAX seeing notable declines. In this environment of cautious sentiment, identifying undervalued stocks can present opportunities for investors seeking value in solid fundamentals and potential for growth despite broader market challenges.

Nilfisk Holding A/S ( CPH:NLFSK ) just released its latest quarterly report and things are not looking great. It was a...

The cBrain A/S ( CPH:CBRAIN ) share price has fared very poorly over the last month, falling by a substantial 28%. The...

H. Lundbeck A/S ( CPH:HLUN B ) just reported healthy earnings but the stock price didn't move much. Our analysis...

Some FLSmidth & Co. A/S ( CPH:FLS ) shareholders may be a little concerned to see that the Group Chief Executive...

Earlier in November 2025, Scandinavian Tobacco Group A/S reported third quarter and nine-month results, revealing declines in both sales and net income compared to the prior year, and announced a narrowing of its full-year earnings guidance due to factors such as US consumer sentiment and currency fluctuations. The company highlighted that US retailer inventory decisions and changes in the USD/DKK exchange rate continue to create meaningful uncertainty for its full-year outlook. We'll...

A.P. Møller Mærsk (CPSE:MAERSK B) shares have edged slightly higher today, continuing a fairly steady performance in recent sessions. Investors are watching the logistics giant’s moves closely, especially given recent shifts in the wider shipping industry. See our latest analysis for A.P. Møller - Mærsk. After a muted start to the year, A.P. Møller - Mærsk has held its ground amidst industry shifts, with its latest share price at DKK 12,550. While short-term share price returns have been...

Vestas Wind Systems (CPSE:VWS) revealed it has secured new orders totaling 347 MW across the USA and Canada for undisclosed projects. This highlights consistent demand for the company’s wind energy solutions in key North American markets. See our latest analysis for Vestas Wind Systems. Momentum in Vestas Wind Systems’ share price has been undeniable lately, with a standout 22.9% 1-month share price return and a robust 45.4% year-to-date gain following news of new North American orders...

Coloplast A/S ( CPH:COLO B ) will increase its dividend from last year's comparable payment on the 9th of December to...

Zealand Pharma (CPSE:ZEAL) just released its third quarter and nine-month results for 2025, showing a dramatic turnaround in both sales and profitability compared to the same periods last year. Investor attention is clearly focused on this shift. See our latest analysis for Zealand Pharma. After a tough start to the year, Zealand Pharma’s third quarter results have injected new optimism into the stock, with momentum clearly picking up as shown by the 24% share price return over the last 90...

Danske Bank has commenced a substantial share buy-back programme of up to DKK 5 billion, executing purchases of 211,000 shares on Nasdaq Copenhagen in the past week, which represents 1.849% of its share capital to date. Share buy-back programmes of this scale can often reflect management’s confidence in the company’s fundamentals and contribute to improving earnings per share through reduced share count. We’ll explore how Danske Bank’s active share repurchases could influence its investment...

On November 18, 2025, Genmab announced that the U.S. Food and Drug Administration granted full approval for EPKINLY (epcoritamab-bysp) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma, expanding its label and confirming prior accelerated approval based on Phase 3 study data. This milestone represents a significant advance for patients with this type of cancer, further strengthening Genmab’s position in developing innovative...

Despite TORM plc's ( CPH:TRMD A ) recent earnings report having lackluster headline numbers, the market responded...

Shareholders appeared unconcerned with Solar A/S' ( CPH:SOLAR B ) lackluster earnings report last week. We did some...

Zealand Pharma A/S ( CPH:ZEAL ) just released its latest third-quarter results and things are looking bullish. Revenue...

Vestas Wind Systems recently reported strong third-quarter earnings, with net income rising to €302 million and sales of €5.34 billion, alongside announcing new wind turbine orders totaling 547 MW across North America and Germany. The combination of improved profitability and significant order intake highlights continued momentum in both Vestas’s financial performance and market demand for its renewable energy solutions. We'll examine how these robust new orders and improved quarterly...

It's been a pretty great week for ALK-Abelló A/S ( CPH:ALK B ) shareholders, with its shares surging 15% to kr.230 in...

Last week, you might have seen that Matas A/S ( CPH:MATAS ) released its quarterly result to the market. The early...

Wondering if Ørsted's recent turbulence means the stock is a hidden bargain or a value trap? You're not alone, and the story behind the numbers is surprisingly layered. After years of struggles, Ørsted’s stock has rebounded 5.4% over the past week and 2.7% in the last 30 days, yet it is still down a striking 63.1% year-to-date and 43.3% over the past year. Recent headlines have centered around Ørsted’s abrupt project cancellations and the company’s ongoing efforts to stabilize its offshore...

Embla Medical has opened a new prosthetic clinic in Kyiv and, at the opening, announced a three-year partnership with the Government of Iceland to deliver prosthetic care and rehabilitation to up to 1,000 Ukrainian amputees, with a total program value of US$11 million co-financed by both parties and supported by Future for Ukraine. This initiative directly addresses Ukraine’s unprecedented need for advanced prosthetic support following the war, highlighting Embla Medical’s commitment to...

FLSmidth (CPSE:FLS) shares have moved slightly higher, trading near DKK 434. Investors are likely watching recent performance and shifting sentiment as the company continues to navigate a challenging industrial landscape in Denmark this month. See our latest analysis for FLSmidth. With FLSmidth’s share price gaining over 20% year-to-date and the one-year total shareholder return above 18%, momentum has stayed firmly positive, even after a recent short-term dip. The stock’s formidable 121%...

DSV recently reached a major sustainability milestone by operating over 400 battery electric trucks across its European network, making it one of the largest electric heavy goods vehicle fleets in Europe. This advancement signals meaningful progress in freight decarbonisation, showcasing how DSV’s investments in route planning and charging infrastructure can deliver zero-emission shipments without sacrificing reliability. We'll explore how DSV’s large-scale rollout of electric trucks may...